Bandaram Pharma Packtech Ltd Stock Price Today (NSE: BANDARAM)
Fundamental Score
Bandaram Pharma Packtech Ltd Share Price — Live NSE/BSE Price, Fundamentals & Analysis
Bandaram Pharma Packtech Ltd share price today is ₹29.93, up +5.20% on NSE/BSE as of 23 June 2026. Bandaram Pharma Packtech Ltd (BANDARAM) is a Small-cap company in the Healthcare Service Provider sector with a market capitalisation of ₹57.02 (Cr). The 52-week high for BANDARAM share price is ₹49.70 and the 52-week low is ₹22.00. At a P/E ratio of 259.20x, BANDARAM is currently trading above its industry average P/E of 39.28x. The company has a Return on Equity (ROE) of 7.94% and a debt-to-equity ratio of 1.71.
Bandaram Pharma Packtech Ltd Share Price Chart — NSE/BSE Historical Performance
Bandaram Pharma Packtech Ltd share price chart: -1.36% return over the past month. 52-week high ₹49.70, 52-week low ₹22.00.
Bandaram Pharma Packtech Ltd — Last 10 Trading Days
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| ₹29.10 | ₹29.99 | ₹29.00 | ₹29.93 | 2.16K (Cr) | |
| ₹27.70 | ₹29.00 | ₹27.01 | ₹28.45 | 2.24K (Cr) | |
| ₹27.69 | ₹28.19 | ₹26.30 | ₹27.01 | 8.52K (Cr) | |
| ₹27.80 | ₹27.82 | ₹26.25 | ₹27.62 | 1.59K (Cr) | |
| ₹29.25 | ₹29.25 | ₹26.00 | ₹27.03 | 2.67K (Cr) | |
| ₹29.25 | ₹29.25 | ₹29.25 | ₹29.25 | 146.00 (Cr) | |
| ₹30.10 | ₹30.10 | ₹28.50 | ₹30.00 | 657.00 (Cr) | |
| ₹30.00 | ₹30.00 | ₹28.26 | ₹29.58 | 27.00 (Cr) | |
| ₹30.07 | ₹30.07 | ₹28.25 | ₹29.00 | 1.54K (Cr) | |
| ₹30.00 | ₹30.00 | ₹27.38 | ₹29.78 | 4.37K (Cr) |
Bandaram Pharma Packtech Ltd — Last 12 Months Price History
| Month | Open | High | Low | Close | Change |
|---|---|---|---|---|---|
| ₹27.70 | ₹29.99 | ₹27.01 | ₹29.93 | +8.05% | |
| ₹25.71 | ₹32.75 | ₹24.01 | ₹27.01 | +5.06% | |
| ₹22.10 | ₹30.00 | ₹22.00 | ₹26.37 | +19.32% | |
| ₹29.50 | ₹34.21 | ₹23.10 | ₹23.53 | -20.24% | |
| ₹25.50 | ₹32.65 | ₹25.50 | ₹29.50 | +15.69% | |
| ₹30.98 | ₹32.01 | ₹26.00 | ₹26.00 | -16.07% | |
| ₹46.90 | ₹49.70 | ₹25.20 | ₹29.77 | -36.52% | |
| ₹23.69 | ₹39.60 | ₹23.35 | ₹39.60 | +67.16% | |
| ₹31.98 | ₹32.99 | ₹22.75 | ₹23.33 | -27.05% | |
| ₹31.95 | ₹37.55 | ₹30.00 | ₹31.40 | -1.72% | |
| ₹41.00 | ₹41.00 | ₹31.15 | ₹32.00 | -21.95% | |
| ₹39.80 | ₹45.50 | ₹35.01 | ₹40.00 | +0.50% |
AI Research Briefing
Powered by Gemini · 2026-04-09
Micro-cap paper stock collapsing under its own stretched valuation and declining fundamentals.
WHAT'S HAPPENING NOW (last 2-4 weeks)
Bandaram Pharma Packtech will hold an Extra Ordinary General Meeting (EGM) on April 27, 2026. Markets Mojo has rated the stock as 'Sell'. The share price hit a 52-week low of on April 1, 2026, marking a 20.03% drop over the prior four days.
CORE STORY (THE REAL GAME)
Bandaram Pharma Packtech is a micro-cap company operating in the recycled paper and paperboard industry, a sector with limited pricing power and high cyclicality. The market seems to be waking up to the stretched valuation and recent underperformance.
- Share price hit 52-week low of ₹22 on April 1, 2026
- Markets Mojo rated the stock as 'Sell'
- Promoter holding decreased by 12.38%
- Significant order wins in the pharma packaging segment
- Successful debt restructuring
- Sharp increase in recycled paper prices
- Micro/SME cap implies high liquidity risk
- Declining promoter holding signals lack of confidence
- High debt-to-equity ratio of 1.71 and low-interest coverage of 1.68x
Promoter holding decreased by 12.38%. FII and DII holdings are negligible.
Healthcare sector in India is increasingly focused on digitization and integrated wellness ecosystems, but Bandaram's core business is paper, not IT.
No. Free Cash Flow 5Y: ₹None Cr
Expect continued pressure on the stock price due to poor financials and negative sentiment. A sustained turnaround is unlikely in the next 3-6 months without significant operational improvements.
Primary Thesis Risk
Inability to service debt will lead to bankruptcy.
For educational purposes only. Not investment advice. Consult a SEBI-registered advisor before investing.
Returns & Performance
Return on Equity (ROE)
Profit generated per ₹1 of shareholder equity
Return on Capital (ROCE)
Returns generated on total capital deployed
Oper. Profit Margin (5Y Avg)
Average operating profit margin over 5 years
Dividend Yield
Annual dividend as % of current share price
Bandaram Pharma Packtech Ltd Valuation Check
Price to Earnings (P/E)
Share price ÷ earnings per share. Lower = cheaper
Industry Avg P/E
Average P/E of all peers in this sector
Market Capitalisation
Total market value of all outstanding shares
Growth Engine
Profit Growth (Quarterly YoY)
Net profit growth vs same quarter last year
Revenue Growth (Quarterly YoY)
Revenue growth vs same quarter last year
Revenue Growth (5-Year CAGR)
Compounded annual revenue growth over 5 years
EPS Growth (5-Year CAGR)
Earnings per share growth over 5 years
Net Profit Growth (5-Year CAGR)
Compounded annual net profit growth over 5 years
Balance Sheet Health
Debt to Equity Ratio
Total debt ÷ equity. Below 0.5 = financially healthy
Interest Coverage Ratio
EBIT ÷ interest expense. Above 2.5 = can pay interest comfortably
Free Cash Flow (5-Year Total)
Cash left after capex over 5 years. Positive = self-funded growth
Labels (e.g., "Excellent", "Good") are peer-based vs industry/sector averages — data-only, not advice
Bandaram Pharma Packtech Ltd Fundamental Analysis & Valuation Benchmarking
Educational evaluation of BANDARAM across key market metrics for learning purposes.
Positive Indicators
3 factors identified
Strong Revenue Growth (92.97%)
Observation: Healthy sales growth indicates market demand and execution capability.
Analysis: Revenue growth >15% suggests strong market position and growth potential.
Balanced Promoter Holding (62.62%)
Observation: Optimal balance between promoter control and public float.
Analysis: Promoter holding in 50-75% range provides management alignment.
Zero Share Pledging Risk
Observation: No promoter shares pledged as collateral.
Analysis: Absence of share pledging eliminates potential forced-selling pressure.
Risk Factors
6 factors identified
Below-Average Return on Equity (7.94%)
Observation: Returns on equity are below industry benchmarks.
Analysis: ROE <10% may indicate inefficient capital utilization. Consider monitoring for operational improvements and management effectiveness.
Suboptimal ROCE (7.67%)
Observation: Returns on capital employed are below expectations.
Analysis: ROCE <10% suggests potential inefficiencies in capital allocation.
Premium Valuation Risk (P/E: 259.20x)
Observation: High valuation multiples may limit upside potential.
Analysis: Elevated P/E ratios require strong growth execution to justify current valuations.
Profit Decline Concern (-91.04%)
Observation: Significant year-over-year profit contraction observed.
Analysis: Declining profitability requires investigation into underlying causes.
Elevated Debt Levels (D/E: 1.71)
Observation: High leverage increases financial risk and interest burden.
Analysis: High debt-to-equity ratios require monitoring of debt servicing capability.
Weak Interest Coverage (1.68x)
Observation: Limited ability to service debt obligations from earnings.
Analysis: Low interest coverage raises concerns about financial stability.
Bandaram Pharma Packtech Ltd vs Healthcare Service Provider Peers
Peer Comparison - Healthcare Service Provider
Compare Bandaram Pharma Packtech Ltd with 10 other companies in the same sector
| Company Info | Fundamental | Valuation | Profitability | Financial Health | Growth | Dividend | ||||
|---|---|---|---|---|---|---|---|---|---|---|
Company Company name | Score Bull Run comprehensive fundamental score based on 20+ metrics | Price Current trading price of the stock | Market Cap Total value of all shares in the market | P/E Price per share divided by earnings per share | ROE Net income divided by shareholder equity | ROCE Earnings before interest and tax divided by capital employed | Debt/Eq Total debt divided by total equity | Profit 5Y Average annual profit growth over 5 years | Sales 5Y Average annual sales growth over 5 years | Dividend Annual dividend per share divided by price per share |
Bandaram Pharma Packtech LtdBandaram Pharma...Selected✓ BANDARAM • 524602 | 0/100 | ₹29.93₹30 | ₹57.02₹57.02 | 259.20Average 259.2 Average | 7.94%Poor 7.94% Poor | 7.67%Poor 7.67% Poor | 1.71Average 1.7 Average | — — | — — | 0.21% |
Dr Lal PathLabs LtdDr Lal PathLabs... LALPATHLAB • 539524 | 64.3/100 | ₹1617.20₹1617 | ₹25557.40₹25557.40 | 47.83Average 47.8 Average | 24.30%Excellent 24.30% Excellent | 28.88%Excellent 28.88% Excellent | 0.07Excellent 0.1 Excellent | 16.69%Excellent 16.69% Excellent | 13.09%Good 13.09% Good | 0.79% |
Vijaya Diagnostic Centre LtdVijaya Diagnost... VIJAYA • 543350 | 53.7/100 | ₹1261.40₹1261 | ₹10272.45₹10272.45 | 67.39Average 67.4 Average | 19.00%Good 19.00% Good | 20.91%Excellent 20.91% Excellent | 0.42Excellent 0.4 Excellent | 18.97%Excellent 18.97% Excellent | 15.00%Excellent 15.00% Excellent | 0.20% |
Metropolis Healthcare LtdMetropolis Heal... METROPOLIS • 542650 | 48.9/100 | ₹536.15₹536 | ₹10124.28₹10124.28 | 63.98Average 64.0 Average | 11.53%Average 11.53% Average | 14.66%Average 14.66% Average | 0.14Excellent 0.1 Excellent | -0.56%Poor -0.56% Poor | 9.22%Good 9.22% Good | 0.20% |
Thyrocare Technologies LtdThyrocare Techn... THYROCARE • 539871 | 40.5/100 | ₹512.15₹512 | ₹7724.80₹7724.80 | 60.48Average 60.5 Average | 16.15%Good 16.15% Good | 24.78%Excellent 24.78% Excellent | 0.05Excellent 0.1 Excellent | -0.64%Poor -0.64% Poor | 9.62%Good 9.62% Good | 1.44% |
Krsnaa Diagnostics LtdKrsnaa Diagnost... KRSNAA • 543328 | 39.6/100 | ₹538.45₹538 | ₹2626.09₹2626.09 | 30.73Average 30.7 Average | 9.29%Poor 9.29% Poor | 12.52%Average 12.52% Average | 0.30Excellent 0.3 Excellent | 22.05%Excellent 22.05% Excellent | 21.41%Excellent 21.41% Excellent | 0.34% |
Suraksha Diagnostic LtdSuraksha Diagno... SURAKSHA • 544293 | 47.1/100 | ₹289.60₹290 | ₹1534.08₹1534.08 | 48.05Average 48.0 Average | 16.46%Good 16.46% Good | 17.84%Good 17.84% Good | 0.51Good 0.5 Good | 16.38%Excellent 16.38% Excellent | 9.86%Good 9.86% Good | 0.00% |
3B Blackbio Diagnostics Ltd3B Blackbio Dia... 3BBLACKBIO • 532067 | 66.1/100 | ₹1225.40₹1225 | ₹1080.56₹1080.56 | 22.01Average 22.0 Average | 19.40%Good 19.40% Good | 25.75%Excellent 25.75% Excellent | 0.00Excellent 0.0 Excellent | 44.03%Excellent 44.03% Excellent | 27.29%Excellent 27.29% Excellent | 0.32% |
One Global Service Provider IncOne Global Serv... ONEGLOBAL • 514330 | 69.5/100 | ₹424.15₹424 | ₹1070.08₹1070.08 | 24.39Average 24.4 Average | 42.31%Excellent 42.31% Excellent | 56.38%Excellent 56.38% Excellent | 0.00Excellent 0.0 Excellent | 128.82%Excellent 128.82% Excellent | — — | 0.00% |
Sastasundar Ventures LtdSastasundar Ven... SASTASUNDR • 533259 | 40.3/100 | ₹313.95₹314 | ₹1042.27₹1042.27 | — — | 4.63%Poor 4.63% Poor | -1.33%Poor -1.33% Poor | 0.01Excellent 0.0 Excellent | 23.31%Excellent 23.31% Excellent | 24.47%Excellent 24.47% Excellent | 0.00% |
46.5/100 | ₹233.90₹234 | ₹826.72₹826.72 | 30.47Average 30.5 Average | 27.08%Excellent 27.08% Excellent | 28.85%Excellent 28.85% Excellent | 0.48Excellent 0.5 Excellent | — — | — — | 0.00% | |
Top Healthcare Service Provider Stocks
View all →By Bull Run Score
By Return on Equity
By Market Cap
- Dr Lal PathLabs Ltd share price25557.40 Cr
- Vijaya Diagnostic Centre Ltd share price10272.45 Cr
- Metropolis Healthcare Ltd share price10124.28 Cr
- Thyrocare Technologies Ltd share price7724.80 Cr
- Krsnaa Diagnostics Ltd share price2626.09 Cr
Bandaram Pharma Packtech Ltd PE Ratio History
Historical price-to-earnings ratio for BANDARAM — last 5 years
| Year | EPS (₹) | Price (₹) | P/E Ratio |
|---|---|---|---|
| FY 2024 | ₹0.79 | ₹45.67 | 57.8x |
P/E = year-end price ÷ diluted EPS from annual filings. Source: NSE/BSE via Bull Run.
Bandaram Pharma Packtech Ltd Dividend History
Annual cash dividends paid by BANDARAM — dividend yield 0.21%
| Financial Year | Dividends Paid (₹ Cr) |
|---|---|
| FY 2025 | ₹0.12 Cr |
Cash dividends from annual cash flow statements. Past dividends do not guarantee future payments. Not investment advice.
Bandaram Pharma Packtech Ltd Quarterly Performance
Latest quarterly metrics for BANDARAM — revenue growth and profit growth vs same quarter last year
Revenue Growth (YoY)
92.97%
Latest quarter vs same quarter previous year
Net Profit Growth (YoY)
-91.04%
Latest quarter net profit vs same quarter previous year
5-Year Revenue CAGR
N/A
Compounded annual revenue growth over 5 years
5-Year Profit CAGR
N/A
Compounded annual net profit growth over 5 years
Bandaram Pharma Packtech Ltd Technical Indicators
SMA 50, SMA 200, RSI and volume signals for BANDARAM — calculated from daily price history
Momentum is balanced — neither overbought nor oversold.
Technical indicators are for educational purposes only. Not investment advice.
Bandaram Pharma Packtech Ltd Financial Statements
Annual income statement, balance sheet and cash flow for Bandaram Pharma Packtech Ltd (BANDARAM) — sourced from NSE/BSE filings.
Loading Financial Statements...
Fetching financial data for Bandaram Pharma Packtech Ltd
About BANDARAM (Bandaram Pharma Packtech Ltd)
Bandaram Pharma Packtech Ltd is a dynamic healthcare service provider dedicated to advancing pharmaceutical packaging solutions. Established with a vision to revolutionize the indu...stry, Bandaram focuses on delivering cutting-edge packaging technologies and services that enhance the safety, efficacy, and presentation of pharmaceutical products. The company’s comprehensive portfolio includes a wide range of packaging materials, innovative designs, and specialized services tailored to meet the unique requirements of pharmaceutical manufacturers and healthcare providers. With a commitment to quality and innovation, Bandaram Pharma Packtech strives to be a trusted partner in the pharmaceutical supply chain, ensuring the integrity and accessibility of life-saving medications. Bandaram Pharma Packtech's core strength lies in its ability to integrate advanced technology with industry expertise to provide customized packaging solutions. The company leverages its state-of-the-art manufacturing facilities and a team of highly skilled professionals to develop and produce packaging that adheres to the strictest regulatory standards. These solutions are not just about containing medication; they are engineered to protect sensitive pharmaceuticals from environmental factors, prevent counterfeiting, and improve patient compliance through user-friendly designs. Bandaram's commitment to sustainability is also evident in its exploration of eco-friendly materials and responsible manufacturing practices, reflecting a deep concern for both patient health and environmental well-being. From blister packs and vials to specialized containers and labeling solutions, Bandaram Pharma Packtech is dedicated to supporting the healthcare industry with reliable and innovative packaging. The company's commitment to customer satisfaction is reflected in its responsiveness, flexibility, and dedication to meeting the evolving needs of its clients. By fostering collaborative partnerships and continually investing in research and development, Bandaram Pharma Packtech aims to stay at the forefront of the industry, providing value-added solutions that contribute to better patient outcomes and a more sustainable future for healthcare.
Company Details
Key Leadership
Corporate Events
BANDARAM Share Price: Frequently Asked Questions
What is the current share price of Bandaram Pharma Packtech Ltd?
Bandaram Pharma Packtech Ltd (BANDARAM) trades at ₹29.93 on NSE and BSE. Market cap ₹57.02 (Cr). Educational data only.
What is the P/E ratio of Bandaram Pharma Packtech Ltd?
Bandaram Pharma Packtech Ltd has a P/E of 259.20x vs industry average 39.28x.
What is the Bull Run score for Bandaram Pharma Packtech Ltd?
Bandaram Pharma Packtech Ltd has a Bull Run score of 0/100 based on 25+ financial parameters.
Does Bandaram Pharma Packtech Ltd pay dividends?
Bandaram Pharma Packtech Ltd has a dividend yield of 0.21%. Past dividends don't guarantee future payments.
What is the ROE of Bandaram Pharma Packtech Ltd?
Bandaram Pharma Packtech Ltd has ROE of 7.94%. Higher ROE indicates better use of shareholder equity.
What is the debt-to-equity ratio of Bandaram Pharma Packtech Ltd?
Bandaram Pharma Packtech Ltd has debt-to-equity of 1.71.
Is Bandaram Pharma Packtech Ltd a good investment?
Bull Run gives Bandaram Pharma Packtech Ltd a score of 0/100. This is not investment advice — consult a SEBI-registered advisor.